Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association - PubMed (original) (raw)
Review
. 2022 Mar;145(9):e722-e759.
doi: 10.1161/CIR.0000000000001040. Epub 2022 Jan 10.
- PMID: 35000404
- DOI: 10.1161/CIR.0000000000001040
Free article
Review
Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
Joshua J Joseph et al. Circulation. 2022 Mar.
Free article
Abstract
Cardiovascular disease remains the leading cause of death in patients with diabetes. Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk factors leads to substantial reductions in cardiovascular events. The 2015 American Heart Association and American Diabetes Association scientific statement, "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence," highlighted the importance of modifying various risk factors responsible for cardiovascular disease in diabetes. At the time, there was limited evidence to suggest that glucose-lowering medications reduce the risk of cardiovascular events. At present, several large randomized controlled trials with newer antihyperglycemic agents have been completed, demonstrating cardiovascular safety and reduction in cardiovascular outcomes, including cardiovascular death, myocardial infarction, stroke, and heart failure. This AHA scientific statement update focuses on (1) the evidence and clinical utility of newer antihyperglycemic agents in improving glycemic control and reducing cardiovascular events in diabetes; (2) the impact of blood pressure control on cardiovascular events in diabetes; and (3) the role of newer lipid-lowering therapies in comprehensive cardiovascular risk management in adults with diabetes. This scientific statement addresses the continued importance of lifestyle interventions, pharmacological therapy, and surgical interventions to curb the epidemic of obesity and metabolic syndrome, important precursors of prediabetes, diabetes, and comorbid cardiovascular disease. Last, this scientific statement explores the critical importance of the social determinants of health and health equity in the continuum of care in diabetes and cardiovascular disease.
Keywords: AHA Scientific Statements; antihypertensive agents; cardiovascular diseases; diabetes complications; hypoglycemic agents; life style; social determinants of health.
Similar articles
- Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association. Fox CS, et al. Circulation. 2015 Aug 25;132(8):691-718. doi: 10.1161/CIR.0000000000000230. Epub 2015 Aug 5. Circulation. 2015. PMID: 26246173 Free PMC article. Review. - Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
Kwan TW, Wong SS, Hong Y, Kanaya AM, Khan SS, Hayman LL, Shah SH, Welty FK, Deedwania PC, Khaliq A, Palaniappan LP; American Heart Association Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Genomic and Precision Medicine. Kwan TW, et al. Circulation. 2023 Jul 4;148(1):74-94. doi: 10.1161/CIR.0000000000001145. Epub 2023 May 8. Circulation. 2023. PMID: 37154053 Review. - Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research; American Diabetes Association. Fox CS, et al. Diabetes Care. 2015 Sep;38(9):1777-803. doi: 10.2337/dci15-0012. Epub 2015 Aug 5. Diabetes Care. 2015. PMID: 26246459 Free PMC article. Review. - Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association. Buse JB, et al. Circulation. 2007 Jan 2;115(1):114-26. doi: 10.1161/CIRCULATIONAHA.106.179294. Epub 2006 Dec 27. Circulation. 2007. PMID: 17192512
Cited by
- Bibliometric and visual analysis of SGLT2 inhibitors in cardiovascular diseases.
Pan R, He Y, Melisandre W, Zhang Y, Su W, Feng J, Jia C, Li S, Liu B. Pan R, et al. Front Pharmacol. 2024 Oct 30;15:1437760. doi: 10.3389/fphar.2024.1437760. eCollection 2024. Front Pharmacol. 2024. PMID: 39539627 Free PMC article. - Systematic review and meta-analysis assessing the status of carotid intima-media thickness and lipid profiles in type 2 diabetes mellitus.
Mashaba RG, Phoswa W, Maimela E, Lebelo S, Modjadji P, Mokgalaboni K. Mashaba RG, et al. BMJ Open. 2024 Nov 9;14(11):e087496. doi: 10.1136/bmjopen-2024-087496. BMJ Open. 2024. PMID: 39521468 Free PMC article. - Plant-Based Diets and Phytochemicals in the Management of Diabetes Mellitus and Prevention of Its Complications: A Review.
Ansari P, Khan JT, Chowdhury S, Reberio AD, Kumar S, Seidel V, Abdel-Wahab YHA, Flatt PR. Ansari P, et al. Nutrients. 2024 Oct 30;16(21):3709. doi: 10.3390/nu16213709. Nutrients. 2024. PMID: 39519546 Free PMC article. Review. - Metformin associates with higher myocardial perfusion reserve and survival in type 2 diabetes mellitus patients.
Sharrack N, Knott KD, Gulsin GS, Kotecha T, Brown LAE, Yeo JL, Porcari A, Adam RD, Thirunavukarasu S, Chowdhary A, Levelt E, Moon JC, McCann GP, Fontana M, Kellman P, Munyombwe T, Gale CP, Buckley DL, Greenwood JP, Swoboda PP, Plein S. Sharrack N, et al. Sci Rep. 2024 Nov 8;14(1):27280. doi: 10.1038/s41598-024-77280-2. Sci Rep. 2024. PMID: 39516499 Free PMC article. - Demographic Differences in Insomnia and Anxiety and the Association with Cardiovascular Risk Factors among Jordanian Healthy Adult.
Al-Smadi AM, Shajrawi A, Gammoh OS, Ashour A, Tawalbeh LI, Harb E, Esmadi H, Al-Akash HY. Al-Smadi AM, et al. Iran J Nurs Midwifery Res. 2024 Sep 4;29(5):555-562. doi: 10.4103/ijnmr.ijnmr_350_22. eCollection 2024 Sep-Oct. Iran J Nurs Midwifery Res. 2024. PMID: 39478724 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical